The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Colonnese Mark P since year 2005.
The trader's CIK number is 1040766.
At the time of this reporting, Colonnese Mark P is the Chief Financial Officer of Nabi Biopharmaceuticals .
(stock ticker symbol NABI).
See this page for all insider trading activities at Nabi Biopharmaceuticals .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-03-20||AGIX||Atherogenics Inc||Option Ex||25,000||.38||9,500|
|2005-12-27||AGIX||Atherogenics Inc||Option Ex||100,000||.33||33,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Colonnese Mark P (Chief Financial Officer of Nabi Biopharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.